Yange Tian
Biographic Data
| ID | 7276492 |
|---|---|
| NAME | Yange Tian |
| GIVEN NAMES | Yange |
| FAMILY NAME | Tian |
| SIGNATURE | TIAN Y |
| AFFILIATIONS | First Affiliated Hospital of Henan University |
| ORCID | 0000-0002-5849-4504 |
| VERIFIED | No |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Integrating single-cell analysis and machine learning to identify COPD hub genes and explore the intervention mechanism of effective component compatibility of Bufei Yishen formula III
Four hub genes (CD74, SOX4, AQP1, and ANXA1) involved in the pathogenesis of endothelial cells in COPD were identified. ECC-BYF III was shown to modulate their expression, supporting its potential as a therapeutic agent in traditional Chinese medicine (TCM) for COPD. These findings offer novel insights into the mechanisms of COPD and open avenues for TCM treatment
Tong Sai granule improves Aecopd via regulation of Mapk-Sirt1-NF-κB pathway and cellular senescence alleviation
Collectively, these results indicate that TSGs ameliorate AECOPD by regulating the MAPK-SIRT1-NF-κB signaling pathway and subsequently suppressing cellular senescence
Network pharmacology analysis uncovers the effect on apoptotic pathway by Bu-Fei formula for COPD treatment
BFF affects COPD by regulating the apoptosis-related pathways and targets
Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling
ECC-BYF II, which consists of paeonol, icariin, nobiletin, total ginsenoside and astragaloside IV, has beneficial effects equivalent to BYF and ECC-BYF I on COPD rats. ECC-BYF II significantly inhibited mucus hypersecretion, which may be related to the regulation of the EGFR/PI3K/mTOR pathway
Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula
these results demonstrated that BYF exerted its anti-COPD efficacy by restoring Th17/Treg balance via reciprocally modulating the activities of STAT3 and STAT5 in COPD rats, which may help to elucidate the underlying immunomodulatory mode of BYF on COPD treatment
Bufei Yishen granules combined with acupoint sticking therapy suppress oxidative stress in chronic obstructive pulmonary disease rats: Via regulating peroxisome proliferator-activated receptor-gamma s…
No prominent works on this page.
Bufei Yishen granules combined with acupoint sticking therapy suppress oxidative stress in chronic obstructive pulmonary disease rats: Via regulating peroxisome proliferator-activated receptor-gamma s…
Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula
these results demonstrated that BYF exerted its anti-COPD efficacy by restoring Th17/Treg balance via reciprocally modulating the activities of STAT3 and STAT5 in COPD rats, which may help to elucidate the underlying immunomodulatory mode of BYF on COPD treatment
Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling
ECC-BYF II, which consists of paeonol, icariin, nobiletin, total ginsenoside and astragaloside IV, has beneficial effects equivalent to BYF and ECC-BYF I on COPD rats. ECC-BYF II significantly inhibited mucus hypersecretion, which may be related to the regulation of the EGFR/PI3K/mTOR pathway
Network pharmacology analysis uncovers the effect on apoptotic pathway by Bu-Fei formula for COPD treatment
BFF affects COPD by regulating the apoptosis-related pathways and targets
Tong Sai granule improves Aecopd via regulation of Mapk-Sirt1-NF-κB pathway and cellular senescence alleviation
Collectively, these results indicate that TSGs ameliorate AECOPD by regulating the MAPK-SIRT1-NF-κB signaling pathway and subsequently suppressing cellular senescence
Integrating single-cell analysis and machine learning to identify COPD hub genes and explore the intervention mechanism of effective component compatibility of Bufei Yishen formula III
Four hub genes (CD74, SOX4, AQP1, and ANXA1) involved in the pathogenesis of endothelial cells in COPD were identified. ECC-BYF III was shown to modulate their expression, supporting its potential as a therapeutic agent in traditional Chinese medicine (TCM) for COPD. These findings offer novel insights into the mechanisms of COPD and open avenues for TCM treatment
Medicine (6 works) · Biology (5 works) · Immunology (4 works) · Internal Medicine (4 works) · COPD (3 works) · Ginseng Biological Effects and Applications (3 works) · Biochemistry (2 works) · Chronic Obstructive Pulmonary Disease (COPD) Research (2 works) · Inflammation (2 works) · Natural product bioactivities and synthesis (2 works)